CCR5 antagonists:: Bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines

被引:36
作者
Lynch, CL
Gentry, AL
Hale, JJ
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Cascieri, MA
Doss, G
Carella, A
Carver, G
Holmes, K
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Emini, EA
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Drug Metab, NMR Spect, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA
关键词
D O I
10.1016/S0960-894X(01)00835-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of CCR5 antagonists containing bicyclic isoxazolidines was generated through a nitrone mediated cycloaddition with olefins bearing the preferred pharmacophores previously described. Potent antagonists (3 and 16) were generated with enhanced affinity for the CCR5 receptor while maintaining antiviral activity against HIV. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:677 / 679
页数:3
相关论文
共 14 条
[1]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[2]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[3]   Asymmetric 1,3-dipolar cycloaddition reactions [J].
Gothelf, KV ;
Jorgensen, KA .
CHEMICAL REVIEWS, 1998, 98 (02) :863-909
[4]   1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity [J].
Hale, JJ ;
Budhu, RJ ;
Holson, EB ;
Finke, PE ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Gould, SL ;
DeMartino, JA ;
Springer, MS ;
Siciliano, S ;
Malkowitz, L ;
Schleif, WA ;
Hazuda, D ;
Miller, M ;
Kessler, J ;
Danzeisen, R ;
Holmes, K ;
Lineberger, J ;
Carella, A ;
Carver, G ;
Emini, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) :2741-2745
[5]   1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements [J].
Hale, JJ ;
Budhu, RJ ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Siciliano, S ;
Gould, SL ;
DeMartino, JA ;
Springer, MS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) :1437-1440
[6]   Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells [J].
Hazuda, DJ ;
Felock, P ;
Witmer, M ;
Wolfe, A ;
Stillmock, K ;
Grobler, JA ;
Espeseth, A ;
Gabryelski, L ;
Schleif, W ;
Blau, C ;
Miller, MD .
SCIENCE, 2000, 287 (5453) :646-650
[7]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659
[8]   OXIDATION OF SECONDARY-AMINES TO NITRONES USING UREA-HYDROGEN PEROXIDE COMPLEX (UHP) AND METAL-CATALYSTS [J].
MARCANTONI, E ;
PETRINI, M ;
POLIMANTI, O .
TETRAHEDRON LETTERS, 1995, 36 (20) :3561-3562
[9]   Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl-1,4′-bipiperidine N-oxide (SCH 351125):: An orally bioavailable human CCR5 antagonist for the treatment of HIV infection [J].
Palani, A ;
Shapiro, S ;
Clader, JW ;
Greenlee, WJ ;
Cox, K ;
Strizki, J ;
Endres, M ;
Baroudy, BM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) :3339-3342
[10]   A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding [J].
Rizzuto, CD ;
Wyatt, R ;
Hernández-Ramos, N ;
Sun, Y ;
Kwong, PD ;
Hendrickson, WA ;
Sodroski, J .
SCIENCE, 1998, 280 (5371) :1949-1953